Muscle and movement development in babies at high risk of motor problems
Studies muscles and movement in the first year, comparing high-risk and typically developing infants.
Key facts
- Who runs it
- University Hospital, Geneva
- Where
- Switzerland1 site in 1 countryChoose a country to see its sites
- Trial code
- Registry title
- Neuro-biomechanical Determinants for Motor Behavior in High-risk Infants
- Status
- Recruiting
- People taking part
- 348 people, planned
- Started
- 10 Oct 2023
- Expected to end
- 31 Dec 2027
- Type of study
- Observational, 2 groups
- Record updated
- 15 November 2023
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for infants at high risk of movement problems, such as very early birth or lack of oxygen at birth. It also takes infants who are developing typically, for comparison.
- Age
- 35 Weeks to 1 Year
- Sex
- All sexes
- Disease stage
- High-risk group: born at or before 28 weeks of pregnancy; or born after 28 weeks with brain injury; or born at term with asphyxia (lack of oxygen, treated with cooling) or newborn stroke. Comparison group: born after 37 weeks, birth weight and head size between P10 and P90, Ph >7.1.
Main reasons for not taking part
- Genetic syndrome
- Problems of the legs, for example spina bifida
- Brain malformations (comparison group)
The registry criteria, word for word
Show all 10 criteriaShow less
Other criteria
- Inclusion \& exclusion criteria for group of high-risk infants:
- Infants born before or at 28 weeks of gestation
- Infants born after 28 weeks of gestation and with brain injury
- A term birth with the clinical diagnosis of asphyxia (ischemic event with hypothermia) or neonatal stroke
- Exclusion in case of genetic syndrome, or lower limb pathology (e.g. spina bifida); Inclusion \& exclusion criteria for group of typically developing children:
- Born at a gestational age above 37 weeks
- Birth weight between P10 and P90
- Head circumference between P10 and P90
- Ph >7.1
- Exclusion in case of genetic syndrome, lower limb pathology and/or brain malformations
This trial has no sites in United States.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
This project focuses on motor development, muscle growth and muscle activity. Using advanced, instrumented tests such as , the link between muscles and the movement characteristics will be studied. In addition, the evolution of these neuro-biomechanical determinants during the first year of life will be investigated. The examinations are planned for a group of high-risk infants (e.g. premature birth, cases of asphyxia, etc.) compared with a group of infants with typical development.
The 2 groups in the trial
- High-risk infants
- Typically developing infants
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorSaves a reminder to your own calendar to look at this page again. Frontlight sends no messages and does not know you set it.
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Neuro-biomechanical Aspects Determining the Motor Behavior in Infants With High-risk of Neuromotor Impairments
- Plain-language title
- Muscle and movement development in babies at high risk of motor problemsGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 14 November 2026.
- Record updated
- 15 November 2023